Lin-Fa Wang to Antibodies, Neutralizing
This is a "connection" page, showing publications Lin-Fa Wang has written about Antibodies, Neutralizing.
Connection Strength
0.207
-
Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand. PLoS One. 2021; 16(2):e0246864.
Score: 0.033
-
Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia. Nat Commun. 2021 02 09; 12(1):972.
Score: 0.033
-
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness. Sci Rep. 2021 01 21; 11(1):2062.
Score: 0.033
-
An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers. Vaccine. 2017 02 22; 35(8):1175-1183.
Score: 0.025
-
Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016 06; 22(6):1071-4.
Score: 0.024
-
Henipavirus neutralising antibodies in an isolated island population of African fruit bats. PLoS One. 2012; 7(1):e30346.
Score: 0.017
-
Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology. MAbs. 2010 Jan-Feb; 2(1):53-66.
Score: 0.015
-
Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2. J Virol Methods. 2021 11; 297:114228.
Score: 0.008
-
Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya. Virol Sin. 2018 Dec; 33(6):484-492.
Score: 0.007
-
Zika virus infection elicits auto-antibodies to C1q. Sci Rep. 2018 01 30; 8(1):1882.
Score: 0.007
-
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen. Vaccine. 2017 12 18; 35(51):7127-7132.
Score: 0.007